TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21537968

Group type: EXPERIMENTAL
Intervention: Visual presentation of action words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory presentation of action words
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control words (visual)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control words (auditory)
Number of subjects: 0
Study: 18291188

Group type: EXPERIMENTAL
Intervention: Bonewax
Number of subjects: 400

Group type: COMPARATOR
Intervention: Nonwax
Number of subjects: 400
Study: 16540959

Group type: EXPERIMENTAL
Intervention: Dobutamine (10 microg.kg.min, n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Physiologic saline (n = 8)
Number of subjects: 16
Study: 12792318

Group type: EXPERIMENTAL
Intervention: Canalith repositioning procedure (CRP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Expectation treatment (control)
Number of subjects: 58
Study: 10739490

Group type: EXPERIMENTAL
Intervention: Mild soap wash with subsequent alcohol-based rinse for degerming
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional antiseptic wash with chlorhexidine-containing detergent
Number of subjects: 16
Study: 8776917

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 1397914

Group type: EXPERIMENTAL
Intervention: Fleet (hypertonic sodium phosphate) enema
Number of subjects: 66

Group type: COMPARATOR
Intervention: Water enema
Number of subjects: 66

Group type: COMPARATOR
Intervention: Golytely (polyethylene glycol electrolyte lavage solution) enema
Number of subjects: 66
Study: 31710382

Group type: EXPERIMENTAL
Intervention: SWEEPS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PIPS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: UAI
Number of subjects: 30
Study: 29708441

Group type: EXPERIMENTAL
Intervention: Autograft fixation with in situ blood coagulum (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Autograft fixation with 10/0 nylon sutures (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 27029851

Group type: EXPERIMENTAL
Intervention: 1000/200 mg of amoxicillin/clavulanate intravenously
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: 2 g of amoxicillin by mouth
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: 600 mg of clindamycin by mouth
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: 600 mg of azithromycin by mouth
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 266
Study: 24285687

Group type: EXPERIMENTAL
Intervention: 160 mg of anthocyanins twice daily for 24 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 22966824

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (scaling, root planing, and oral hygiene instructions)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy
Number of subjects: 317
Study: 19921083

Group type: EXPERIMENTAL
Intervention: Alendronate (5 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no alendronate)
Number of subjects: 20
Study: 19045965

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Maintenance antidepressant medication (m-ADM)
Number of subjects: 123
Study: 17145251

Group type: EXPERIMENTAL
Intervention: Long-term therapeutic tinzaparin subcutaneously once daily for 3 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care long-term vitamin-K-antagonist therapy for 3 months
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Long-term therapeutic tinzaparin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care long-term vitamin-K-antagonist therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 14687502

Group type: EXPERIMENTAL
Intervention: 250 U/0.5 ml/dose of Healive vaccine
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 500 U/1.0 ml/dose of Healive vaccine
Number of subjects: 85
Study: 10874279

Group type: EXPERIMENTAL
Intervention: Supervised, high-intensity exercise training for 8 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (untrained patients)
Number of subjects: 25
Study: 9013098

Group type: EXPERIMENTAL
Intervention: Parenteral oestrogen therapy (polyestradiol phosphate 240 mg i.m. every month)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Orchidectomy (surgical castration)
Number of subjects: 10
Study: 1327850

Group type: EXPERIMENTAL
Intervention: Oral slow-release theophylline
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3901372

Group type: EXPERIMENTAL
Intervention: Tobramycin plus Clindamycin
Number of subjects: 112

Group type: COMPARATOR
Intervention: Cefoxitin plus Placebo
Number of subjects: 112
Study: 30503052

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional Intervention Group (CIG)
Number of subjects: 83
Study: 29878102

Group type: EXPERIMENTAL
Intervention: Anaesthesiologist-directed sedation (ADS)
Number of subjects: 1242

Group type: COMPARATOR
Intervention: Proceduralist-directed sedation (PDS)
Number of subjects: 1242
Study: 27570988

Group type: EXPERIMENTAL
Intervention: Intervention arm with pharmacist review of chronic medication according to STOPP‐START criteria; recommendations sent to Primary Care Physician.
Number of subjects: 665

Group type: COMPARATOR
Intervention: Control arm receiving standard of care without systematic review of adequacy to STOPP‐START criteria.
Number of subjects: 665
Study: 25105567

Group type: EXPERIMENTAL
Intervention: Active anodal tDCS (1mA) during treadmill training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo tDCS during treadmill training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Active anodal tDCS (1mA)
Number of subjects: 24
Study: 22364258

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Rosuvastatin
Number of subjects: 70
Study: 20827560

Group type: EXPERIMENTAL
Intervention: Remifentanil-based general anesthesia
Number of subjects: 210

Group type: COMPARATOR
Intervention: Fentanyl-based conventional anesthesia
Number of subjects: 210
Study: 18155216

Group type: EXPERIMENTAL
Intervention: 0.4% sodium hyaluronate solution
Number of subjects: 140

Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 140
Study: 15991510

Group type: EXPERIMENTAL
Intervention: 15 mg hyperbaric ropivacaine + 10 microg fentanyl
Number of subjects: 37
Study: 12182261

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg once daily)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Atenolol (50 mg once daily)
Number of subjects: 280
Study: 10427944

Group type: EXPERIMENTAL
Intervention: C-LASA (categorical linear analogue scale)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Swedish instrument (developed by Glimelius et al.)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: C-LASA and Swedish instrument (global dimension)
Number of subjects: 26
Study: 8749883

Group type: EXPERIMENTAL
Intervention: Early warning signs (EWS) of impending relapse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical action based on EWS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terminology usage
Number of subjects: 0
Study: 1851071

Group type: EXPERIMENTAL
Intervention: [2H5]phenylalanine method
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: [13C]leucine method (primary pool)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: [13C]leucine method (reciprocal pool)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Insulin infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Insulin withdrawal
Number of subjects: 6
Study: 7009311

Group type: EXPERIMENTAL
Intervention: Percutaneous transhepatic variceal obliteration
Number of subjects: 116

Group type: COMPARATOR
Intervention: Transhepatic sclerotherapy
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Follow-up portography
Number of subjects: 116
Study: 30113919

Group type: EXPERIMENTAL
Intervention: Bioceramic pants (BIO)
Number of subjects: 20
Study: 31207854

Group type: EXPERIMENTAL
Intervention: 12-week group-based integrative cognitive remediation (n=25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waiting-list control group (n=24)
Number of subjects: 49
Study: 28619613

Group type: EXPERIMENTAL
Intervention: Supplemental photodynamic therapy (PDT) in one-visit treatment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Supplemental photodynamic therapy (PDT) in two-visit treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chemo-mechanical preparation (CMP) alone in two-visit treatment
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Supplemental photodynamic therapy (PDT)
Number of subjects: 24
Study: 25425224

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 51
Study: 24816724

Group type: EXPERIMENTAL
Intervention: Cetuximab, capecitabine, and irinotecan
Number of subjects: 146
Study: 22933048

Group type: EXPERIMENTAL
Intervention: Test formulation of olanzapine (10 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation of olanzapine (10 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 24
Study: 19427263

Group type: EXPERIMENTAL
Intervention: Therapeutic CPAP
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo CPAP
Number of subjects: 36
Study: 17540198

Group type: EXPERIMENTAL
Intervention: Dexamet stent
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 120
Study: 15809124

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EA)
Number of subjects: 210

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Combination of GA and EA (CA)
Number of subjects: 210
Study: 12136612

Group type: EXPERIMENTAL
Intervention: K+ channel blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional anti‐arrhythmic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti‐arrhythmic drug selection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti‐arrhythmic treatment
Number of subjects: 0
Study: 10440638

Group type: EXPERIMENTAL
Intervention: 400 mg metronidazole administered at 8-hour intervals for 1 week
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo administered at 8-hour intervals for 1 week
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 400 mg metronidazole
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 7767709

Group type: EXPERIMENTAL
Intervention: Periodontal hygienic treatment (n = 11 after treatment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Before treatment (n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy gingival samples (control group, n = 4)
Number of subjects: 20
Study: 2181860

Group type: EXPERIMENTAL
Intervention: 40 mmol Mg aspartate (20 mmol elemental Mg twice daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 7365607

Group type: EXPERIMENTAL
Intervention: Discussion groups with a nurse co-ordinator and a veteran mother, held for seven to ten weeks.
Number of subjects: 57
Study: 31981597

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 74
Study: 31461138

Group type: EXPERIMENTAL
Intervention: AVP (4 U bolus, then ≤0.04 U/min for 48 hours)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: AVP
Number of subjects: 100
Study: 28064343

Group type: EXPERIMENTAL
Intervention: VisQ method (quantitative interpretation)
Number of subjects: 80

Group type: COMPARATOR
Intervention: VisVis control (visual read only)
Number of subjects: 80
Study: 26366886

Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive behavioral therapy (CBT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 100
Study: 23489638

Group type: EXPERIMENTAL
Intervention: Body and Soul program
Number of subjects: 8

Group type: COMPARATOR
Intervention: Colon cancer screening intervention
Number of subjects: 8
Study: 21094572

Group type: EXPERIMENTAL
Intervention: Rapid prototyping (RP) for TMJ surgery
Number of subjects: 11

Group type: COMPARATOR
Intervention: Traditional surgery (Control)
Number of subjects: 11
Study: 19706190

Group type: EXPERIMENTAL
Intervention: Peer educators
Number of subjects: 135

Group type: COMPARATOR
Intervention: Group members (not peer educators)
Number of subjects: 135
Study: 17182183

Group type: EXPERIMENTAL
Intervention: Nortriptyline (25-100 mg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Morphine (15-90 mg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combination of morphine and nortriptyline
Number of subjects: 61

Group type: COMPARATOR
Intervention: Benztropine (active placebo, 0.25-1 mg)
Number of subjects: 61
Study: 15539665

Group type: EXPERIMENTAL
Intervention: Colombian antivenom (20 ml initial dose)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Colombian antivenom (< 70 ml initial dose)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Brazilian antivenom
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Colombian antivenom
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Ecuadorian antivenom
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: All antivenoms
Number of subjects: 210
Study: 11185630

Group type: EXPERIMENTAL
Intervention: telmisartan 160 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: hydrochlorothiazide 25 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: telmisartan 160 mg plus hydrochlorothiazide 25 mg
Number of subjects: 13
Study: 9103344

Group type: EXPERIMENTAL
Intervention: Synthroid
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Levoxine (Levoxyl)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Generic levothyroxine sodium preparations
Number of subjects: 22

Group type: COMPARATOR
Intervention: All products (Synthroid, Levoxine, and 2 generic preparations)
Number of subjects: 22
Study: 1503098

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN alpha) at a dose of 3 megaunits three times a week intramuscularly for 1 year
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 45
Study: 6094423

Group type: EXPERIMENTAL
Intervention: Ro 09‐0415, 1200 mg bd orally before and after challenge with rhinovirus type 9
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30892045

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IF) for 8 weeks
Number of subjects: 0
Study: 28731882

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention for preventing osteoporosis (n = 26)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Stretching exercise (exercise placebo intervention) (n = 25)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention for preventing osteoporosis
Number of subjects: 51

Group type: COMPARATOR
Intervention: Stretching exercise (exercise placebo intervention)
Number of subjects: 51
Study: 26873954

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy with stent retrievers
Number of subjects: 5

Group type: COMPARATOR
Intervention: Standard care (including IV thrombolysis)
Number of subjects: 5
Study: 25559798

Group type: COMPARATOR
Intervention: Placebo (arm A)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Linifanib 7.5 mg (arm B)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Linifanib 12.5 mg (arm C)
Number of subjects: 138
Study: 21885210

Group type: EXPERIMENTAL
Intervention: Osmotic release methylphenidate (OROS-MPH)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Adolescents with MDD
Number of subjects: 303
Study: 20478360

Group type: EXPERIMENTAL
Intervention: Neurofeedback training for 15 weeks, 30 sessions of 22 min each
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham neurofeedback
Number of subjects: 27
Study: 18771979

Group type: EXPERIMENTAL
Intervention: Measurement of placenta growth factor (PLGF) at baseline and follow-up
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Measurement of inhibin A at follow-up
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Measurement of soluble fms‐like tyrosine kinase‐1 (sFlt‐1) at follow-up
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Changes in markers from baseline to follow-up
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Baseline markers for PE less than 27 weeks
Number of subjects: 704
Study: 15878729

Group type: EXPERIMENTAL
Intervention: Event-based timing tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emergent timing tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group performance
Number of subjects: 0
Study: 12631397

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 280

Group type: COMPARATOR
Intervention: No endocrine treatment
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 280

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 280
Study: 10536556

Group type: EXPERIMENTAL
Intervention: Org 9487 (1.5 mg kg‐1 initial dose followed by three repeat doses or a 30‐min infusion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rocuronium (two incremental doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neostigmine administration after Org 9487
Number of subjects: 0
Study: 8911197

Group type: EXPERIMENTAL
Intervention: 22-gauge Sprotte pencil-point-tip needles
Number of subjects: 138

Group type: COMPARATOR
Intervention: 22-gauge Quinke bevel-tip end-hole needles
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Gertie Marx pencil-point-tip needles
Number of subjects: 138
Study: 1909471

Group type: COMPARATOR
Intervention: Ivermectin
Number of subjects: 904
Study: 367024

Group type: EXPERIMENTAL
Intervention: Diluted heparin 5 000 IU/ml
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Concentrated heparin 25 000 IU/ml
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control group (no heparin)
Number of subjects: 167
Study: 31702876

Group type: COMPARATOR
Intervention: Trivalent inactivated influenza vaccine (TIV)
Number of subjects: 3014

Group type: EXPERIMENTAL
Intervention: Trivalent live attenuated influenza vaccine (TLAIV)
Number of subjects: 3014

Group type: COMPARATOR
Intervention: Hepatitis A vaccine
Number of subjects: 3014
Study: 31373658

Group type: EXPERIMENTAL
Intervention: Pathway to Health Program
Number of subjects: 0
Study: 28372682

Group type: EXPERIMENTAL
Intervention: Stylet group (20 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 40
Study: 25708453

Group type: COMPARATOR
Intervention: Experience Corps(®) program (EC); high intensity (>15 h per week) involvement of older adult volunteers in schools.
Number of subjects: 0
Study: 23850035

Group type: EXPERIMENTAL
Intervention: Practical training for intrapartum emergencies
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Annual training
Number of subjects: 140
Study: 21808077

Group type: EXPERIMENTAL
Intervention: Coaction condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additive condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conjunctive condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual control condition
Number of subjects: 0
Study: 19821984

Group type: EXPERIMENTAL
Intervention: Internet-based self-help problem-solving therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 15729083

Group type: EXPERIMENTAL
Intervention: Hypericum extract (900 mg/day)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 12660503

Group type: EXPERIMENTAL
Intervention: Kidney recipients receiving oral prednisone (20 patients)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Liver recipients receiving oral prednisone (6 patients)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lung recipients receiving ketoconazole and CsA or tacrolimus (8 patients)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 34
Study: 10202365

Group type: EXPERIMENTAL
Intervention: CMPA children under age 3 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CMPA children over age 9 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Children who lost sensitivity to milk
Number of subjects: 0
Study: 7786927

Group type: EXPERIMENTAL
Intervention: Thermal biofeedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 2243846

Group type: EXPERIMENTAL
Intervention: 0.5% silver nitrate (Ag)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Neomycin (1 gm/liter) plus bacitracin (50,000 units/liter) (NB)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ringer's lactate (RL)
Number of subjects: 52
Study: 580598

Group type: EXPERIMENTAL
Intervention: Chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Radiotherapy with total body irradiation (TBI)
Number of subjects: 72
Study: 30458737

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lexia Reading (active-control group)
Number of subjects: 0
Study: 27473046

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 43
Study: 25266443

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5FU) and leucovorin (LV) as bolus injections (Mayo or modified Mayo) or bi-monthly with bolus and continuous infusion (LV5FU2 or simplified LV5FU2)
Number of subjects: 1033
Study: 22705346

Group type: COMPARATOR
Intervention: Ready-made spectacles (RMS)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Custom spectacles (CS)
Number of subjects: 363